Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barnaby Pickering

Reporter

London, UK

Barnaby lives and works in Yorkshire. Having graduated from University College London with a master's degree in biomedical engineering in 2020, Barnaby is passionate about cutting-edge medical technology. Key areas of focus for Barnaby include diabetes, nanotechnology, machine learning and artificial intelligence.

Latest From Barnaby Pickering

Dexcom Touts G7 As ‘The Most Accurate CGM’ As It Prepares For US Launch

The US FDA has granted authorization to Dexcom to market its G7 continuous glucose monitor, which the company will launch in the next couple of months.

Diabetic Care Approvals

Deals Shaping The Medtech And Diagnostics Industry, December 2022

Medtech Insight's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – in vitro diagnostics and medical devices – and then categorized by type – acquisition, alliance, or financing. This month’s column covers deals announced in November 2022. Data provided by Citeline's Biomedtracker.

Deals M & A

Elypta Drops Data Showing Power Of Metabolite-Based MCED Test

Elypta’s MIRAM kit for multi-cancer early detection performed well in a large-scale study.

Cancer Diagnostics

Minute Insight: Intel-Penn Tie-Up Proves Federated Approach’s Power

Federated learning has taken another step forward thanks to new research that proves it is better at spotting brain tumors. 

Innovation Artificial Intelligence

Snapshot: November Highlights

A selection of articles you might have missed from November 2022, during which In Vivo shone the spotlight on the Asia Pacific region.

BioPharmaceutical Strategy

GE Finalizes Details Of GE HealthCare Spin-Off

Over four years in the making, the deal will spin-off General Electric’s health care business into a separate public company.

Medical Device Commercial
See All
UsernamePublicRestriction

Register